Neurocrine Biosciences Presents at CIBC World Markets 15th Annual Health Care Conference
SAN DIEGO, Nov 5, 2004 /PRNewswire-FirstCall via COMTEX/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will present at the CIBC World Markets 15th Annual Health Care Conference on Monday, November 8, 2004 at 11:30AM Eastern Standard Time (EST) / 8:30AM Pacific Standard Time (PST). The presentation will be simultaneously webcast and can be accessed on the Company's website at http://www.neurocrine.com or via a link provided by CIBC World Markets at http://www.veracast.com/webcasts/cibcwm/healthcare04/73108352.cfm
Gary Lyons, President and Chief Executive Officer of Neurocrine Biosciences will report on indiplon, the Company's recently submitted New Drug Application for the treatment of multiple forms of insomnia as well as highlight the Company's diverse research and development programs.
If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Jones or Elizabeth Foster. A replay will become available approximately one hour after the live webcast concludes. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. The presentation will be archived until Monday, November 22, 2004.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, certain female and male disorders, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com.
SOURCE Neurocrine Biosciences, Inc.
Claudia Jones or Elizabeth Foster, of Neurocrine Biosciences, +1-858-617-7600
http://www.neurocrine.com